Literature DB >> 11932234

Innate immunity to Mycobacterium tuberculosis.

Reinout van Crevel1, Tom H M Ottenhoff, Jos W M van der Meer.   

Abstract

The different manifestations of infection with Mycobacterium tuberculosis reflect the balance between the bacillus and host defense mechanisms. Traditionally, protective immunity to tuberculosis has been ascribed to T-cell-mediated immunity, with CD4(+) T cells playing a crucial role. Recent immunological and genetic studies support the long-standing notion that innate immunity is also relevant in tuberculosis. In this review, emphasis is on these natural, innate host defense mechanisms, referring to experimental data (e.g., studies in gene knockout mice) and epidemiological, immunological, and genetic studies in human tuberculosis. The first step in the innate host defense is cellular uptake of M. tuberculosis, which involves different cellular receptors and humoral factors. Toll-like receptors seem to play a crucial role in immune recognition of M. tuberculosis, which is the next step. The subsequent inflammatory response is regulated by production of pro- and anti-inflammatory cytokines and chemokines. Different natural effector mechanisms for killing of M. tuberculosis have now been identified. Finally, the innate host response is necessary for induction of adaptive immunity to M. tuberculosis. These basic mechanisms augment our understanding of disease pathogenesis and clinical course and will be of help in designing adjunctive treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11932234      PMCID: PMC118070          DOI: 10.1128/CMR.15.2.294-309.2002

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  257 in total

1.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

Authors:  A van Rie; R Warren; M Richardson; T C Victor; R P Gie; D A Enarson; N Beyers; P D van Helden
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

Review 2.  Cytokine/chemokine cascades in immunity to tuberculosis.

Authors:  I M Orme; A M Cooper
Journal:  Immunol Today       Date:  1999-07

3.  Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice.

Authors:  I Sugawara; H Yamada; H Kaneko; S Mizuno; K Takeda; S Akira
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis.

Authors:  S A Fulton; J M Johnsen; S F Wolf; D S Sieburth; W H Boom
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool.

Authors:  J P Rosat; E P Grant; E M Beckman; C C Dascher; P A Sieling; D Frederique; R L Modlin; S A Porcelli; S T Furlong; M B Brenner
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

6.  Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages.

Authors:  P Pancholi; A Mirza; N Bhardwaj; R M Steinman
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

7.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis.

Authors:  K Law; M Weiden; T Harkin; K Tchou-Wong; C Chi; W N Rom
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

9.  Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis.

Authors:  A M Cooper; J E Callahan; M Keen; J T Belisle; I M Orme
Journal:  Tuber Lung Dis       Date:  1997

10.  Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin.

Authors:  A Molloy; P Laochumroonvorapong; G Kaplan
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  182 in total

1.  Mycobacterium tuberculosis serine protease Rv3668c can manipulate the host-pathogen interaction via Erk-NF-κB axis-mediated cytokine differential expression.

Authors:  Quanju Zhao; Wu Li; Tian Chen; Ying He; Wanyan Deng; Hongping Luo; Jianping Xie
Journal:  J Interferon Cytokine Res       Date:  2014-03-31       Impact factor: 2.607

2.  BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial.

Authors:  Melanie A Gasper; Anneke C Hesseling; Isaac Mohar; Landon Myer; Tali Azenkot; Jo-Ann S Passmore; Willem Hanekom; Mark F Cotton; I Nicholas Crispe; Donald L Sodora; Heather B Jaspan
Journal:  JCI Insight       Date:  2017-04-06

Review 3.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

4.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

5.  Essential engagement of Toll-like receptor 2 in initiation of early protective Th1 response against rough variants of Mycobacterium abscessus.

Authors:  Jong-Seok Kim; Min-Jung Kang; Woo Sik Kim; Seung Jung Han; Hong Min Kim; Ho Won Kim; Kee Woong Kwon; So Jeong Kim; Seung Bin Cha; Seok-Yong Eum; Won-Jung Koh; Sang-Nae Cho; Jong-Hwan Park; Sung Jae Shin
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

6.  Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response.

Authors:  M Lichtner; R Rossi; F Mengoni; S Vignoli; B Colacchia; A P Massetti; I Kamga; A Hosmalin; V Vullo; C M Mastroianni
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

7.  Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB.

Authors:  Seok-Yong Eum; Ji-Hye Kong; Min-Sun Hong; Ye-Jin Lee; Jin-Hee Kim; Soo-Hee Hwang; Sang-Nae Cho; Laura E Via; Clifton E Barry
Journal:  Chest       Date:  2009-09-11       Impact factor: 9.410

8.  Lower levels of interleukin-12 precede the development of tuberculosis among HIV-infected women.

Authors:  José Bordón; Michael W Plankey; Mary Young; Ruth M Greenblatt; Maria C Villacres; Audrey L French; Jie Zhang; Guy Brock; Savitri Appana; Betsy Herold; Helen Durkin; Jonathan E Golub; Rafael Fernandez-Botran
Journal:  Cytokine       Date:  2011-08-30       Impact factor: 3.861

9.  Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages.

Authors:  K C Wong; W M Leong; H K W Law; K F Ip; J T H Lam; K Y Yuen; P L Ho; W S Tse; X H Weng; W H Zhang; S Chen; W C Yam
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

10.  Attenuated heme oxygenase-1 responses predispose the elderly to pulmonary nontuberculous mycobacterial infections.

Authors:  Ranu Surolia; Suman Karki; Zheng Wang; Tejaswini Kulkarni; Fu Jun Li; Shikhar Vohra; Hitesh Batra; Jerry A Nick; Steven R Duncan; Victor J Thannickal; Adrie J C Steyn; Anupam Agarwal; Veena B Antony
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-30       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.